 Connection
Michael Schoenbaum to Antipsychotic Agents
This is a "connection" page, showing publications Michael Schoenbaum has written about Antipsychotic Agents.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.452 |
|
|
|
-
Schoenbaum M, Sutherland JM, Chappel A, Azrin S, Goldstein AB, Rupp A, Heinssen RK. Twelve-Month Health Care Use and Mortality in Commercially Insured Young People With Incident Psychosis in the United States. Schizophr Bull. 2017 10 21; 43(6):1262-1272.
Score: 0.452
-
Olfson M, King M, Schoenbaum M. Stimulant Treatment of Young People in the United States. J Child Adolesc Psychopharmacol. 2016 08; 26(6):520-6.
Score: 0.405
-
Olfson M, King M, Schoenbaum M. Treatment of Young People With Antipsychotic Medications in the United States. JAMA Psychiatry. 2015 Sep; 72(9):867-74.
Score: 0.390
-
Sultan RS, Correll CU, Schoenbaum M, King M, Walkup JT, Olfson M. National Patterns of Commonly Prescribed Psychotropic Medications to Young People. J Child Adolesc Psychopharmacol. 2018 04; 28(3):158-165.
Score: 0.115
-
Wang PS, Ulbricht CM, Schoenbaum M. Improving mental health treatments through comparative effectiveness research. Health Aff (Millwood). 2009 May-Jun; 28(3):783-91.
Score: 0.063
-
Larkin I, Ang D, Steinhart J, Chao M, Patterson M, Sah S, Wu T, Schoenbaum M, Hutchins D, Brennan T, Loewenstein G. Association Between Academic Medical Center Pharmaceutical Detailing Policies and Physician Prescribing. JAMA. 2017 May 02; 317(17):1785-1795.
Score: 0.027
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|